Miriam
Saiz Rodriguez
Instituto de Salud Carlos III
Madrid, EspañaPublicacións en colaboración con investigadores/as de Instituto de Salud Carlos III (4)
2019
-
Prediction models for voriconazole pharmacokinetics based on pharmacogenetics: AN exploratory study in a Spanish population
International Journal of Antimicrobial Agents, Vol. 54, Núm. 4, pp. 463-470
2018
-
Effect of ABCB1 C3435T Polymorphism on Pharmacokinetics of Antipsychotics and Antidepressants
Basic and Clinical Pharmacology and Toxicology, Vol. 123, Núm. 4, pp. 474-485
-
Influence of CYP2D6, CYP3A4, CYP3A5 and ABCB1 Polymorphisms on Pharmacokinetics and Safety of Aripiprazole in Healthy Volunteers
Basic and Clinical Pharmacology and Toxicology, Vol. 122, Núm. 6, pp. 596-605
-
Pharmacogenetics and Pharmacogenomics in Moderate-to-Severe Psoriasis
American Journal of Clinical Dermatology, Vol. 19, Núm. 2, pp. 209-222